semaglutide cardiovascular outcomes news 2025 october SELECT: Semaglutide's Impact on CVD Events Emerges Quickly Cardiovascular Outcomes Associated with Semaglutide

Wong ND, Sattar N

For your convenience, we recommend wearing comfortable clothing that allows easy access to the injection site, typically the upper arm or buttock

Int J Mol Sci 25(8):4463 Kahaly GJ (2020) Management of Graves thyroidal and extrathyroidal disease: an update

No validated PHQ-2 or PHQ-9 , no dedicated eating-disorder screen, no blood pressure or resting heart rate , no diet history beyond the single 3-option lifestyle self-rating, no exercise history , no broader comorbidity multi-select for hypertension, sleep apnea, NAFLD, PCOS, or GERD, no AUDIT-C -style alcohol quantity-frequency questions, no recreational drug naming (cocaine, opioids, kratom, methamphetamine, cannabis are not asked separately), no pregnancy or breastfeeding screen, no cardiac sudden-death family history , no MEN-2 named separately , no ID upload , and no phone OTP

The problem gets worse: Some journals that acknowledged mistakes required a substantial fee to publish our letters: we were asked to spend our research dollars on correcting other peoples mistakes. One unnamed publisher even had the gall to declare that it would exact a fee of $10,000 from authors of withdrawn papers a draconian amount that clearly poses a disincentive to doing the right thing

doi: 10.3390/nu15153324